The Economic Impact of a Bioterrorist Attack: Are Prevention and Postattack Intervention Programs Justifiable?
Open Access
- 1 June 1997
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 3 (2) , 83-94
- https://doi.org/10.3201/eid0302.970201
Abstract
Volume 3, Number 2—June 1997 - Emerging Infectious Disease journal - CDCKeywords
This publication has 19 references indexed in Scilit:
- The Specter of Biological WeaponsScientific American, 1996
- Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades InfecciosasAntimicrobial Agents and Chemotherapy, 1995
- The Sverdlovsk Anthrax Outbreak of 1979Science, 1994
- Postexposure Prophylaxis against Experimental Inhalation AnthraxThe Journal of Infectious Diseases, 1993
- Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.Proceedings of the National Academy of Sciences, 1993
- AIRBORNE SPREAD OF BRUCELLOSISAnnals of the New York Academy of Sciences, 1980
- Antibiotic prophylaxis and therapy of airborne tularemia.1966
- Aerobiology.1963
- Tularemia Vaccine StudyArchives of internal medicine (1960), 1961
- BrucellosisA.M.A. Archives of Internal Medicine, 1959